Abstract Number: 2152 • 2013 ACR/ARHP Annual Meeting
Predicting Benefit From Lateral Wedge Orthotics Using Radiographic Parameters In Medial Knee Osteoarthritis
Background/Purpose: Lateral wedge foot orthosis have been used therapeutically in patients with medial knee osteoarthritis (OA) with inconsistent results. The current theory suggests they reduce…Abstract Number: 2153 • 2013 ACR/ARHP Annual Meeting
Arrest Of Progressive Loss Of Vibratory Perception In Knee Osteoarthritis: Effects Of a 48 Week Biomechanical Intervention
Background/Purpose: Somatosensory function has been shown to be altered in knee osteoarthritis (OA); for example, we previously observed that in knee OA there are…Abstract Number: 2154 • 2013 ACR/ARHP Annual Meeting
Improvement In Clinical Symptoms After 48 Weeks Of Wearing Flexible Footwear In Osteoarthritis Of Knee: A Randomized Placebo-Controlled Study
Background/Purpose: Osteoarthritis (OA), the most common form of arthritis, is a major cause of pain and disability. Biomechanical interventions that reduce dynamic loading are…Abstract Number: 2155 • 2013 ACR/ARHP Annual Meeting
Beneficial Effect Of Long-Term Use Of a Low-Cost Minimalist Footwear On Joint Load, Clinical, and Functional Aspects Of Elderly Women With Knee Osteoarthritis
Background/Purpose: Positive outcomes of minimalist shoes on reduction of overload in patients with knee osteoarthritis (OA) have been highlighted. We have recently shown beneficial effects…Abstract Number: 2156 • 2013 ACR/ARHP Annual Meeting
Weight Change Has A Disease Modifying Effect On Knee Structure and Symptoms In Obese Individuals Without Diagnosed Knee Osteoarthritis
Background/Purpose: Although the strongest modifiable risk factor for the development of knee osteoarthritis (OA) is obesity, there are a paucity of data examining the effects…Abstract Number: 2157 • 2013 ACR/ARHP Annual Meeting
Understanding Differences Between Black and White Patients’ Reactions to New Treatment
Background/Purpose: Numerous studies have found that Black patients are more risk averse than their White counterparts. In clinical practice, patients make judgments based on oral…Abstract Number: 2158 • 2013 ACR/ARHP Annual Meeting
Do Numbers Make a Difference?
Background/Purpose: Patients frequently overweigh the risks associated with rare adverse events (AEs). This is particularly true for biologics associated with extremely rare AEs. As a…Abstract Number: 2159 • 2013 ACR/ARHP Annual Meeting
Understanding the Preference to Stay With the Status Quo
Background/Purpose: Preference for the status quo is prevalent in patients with rheumatic disease and may be harmful in decisions for which there is strong evidence…Abstract Number: 2161 • 2013 ACR/ARHP Annual Meeting
Biopsychosocial Typologies of Pain in a Cohort of Patients With Systemic Sclerosis
Background/Purpose: Despite being a common problem in Systemic Sclerosis, the extant literature on pain has primarily focused on biomedical correlates, or bivariate relationships with a…Abstract Number: 2162 • 2013 ACR/ARHP Annual Meeting
Physical, Psychological, and Social Impacts Of Restricting Back Pain: The Older Person’s Perspective
Background/Purpose: Although back pain is the most common type of pain reported by older adults, we have a limited understanding of its impact on the…Abstract Number: 2163 • 2013 ACR/ARHP Annual Meeting
Predictors Of No Improvement In Subjective Health Perception In Newly Diagnosed Rheumatoid Athritis Patients With a Good DAS28 Response At 12 Months In The Dutch Rheumatoid Arthritis Monitoring Tight Control Cohort
Background/Purpose: Modern treatment strategies are highly successful in reducing disease activity in rheumatoid arthritis (RA). However, changes in clinical measures of disease activity may not…Abstract Number: 2164 • 2013 ACR/ARHP Annual Meeting
Rituximab In The Treatment Of Children With Systemic LUPUS Erythematosus: ONE Year Analysis Of 12 Patients
Background/Purpose: Treatment of childhood systemic lupus erythematosus (SLE) is an ongoing problem because of the severity of the disease in some patients and the side-effects…Abstract Number: 2165 • 2013 ACR/ARHP Annual Meeting
Efficacy and Safety Of Biologic Agents In Patients With Poly-Articular Juvenile Idiopathic Arthritis: Network Meta-Analysis Of Randomized Controlled Withdrawal Trials
Background/Purpose: Although various biologic agents (BAs) are in use for polyarticular juvenile idiopathic arthritis (pJIA), a combined meta-analytic summary comparing the efficacy and safety among…Abstract Number: 2166 • 2013 ACR/ARHP Annual Meeting
Infection Risk With Tumor Necrosis Factor Inhibitor Use In Polyarticular Juvenile Idiopathic Arthritis
Background/Purpose: Tumor Necrosis Factor inhibitors (TNFi) are extremely effective in treating Juvenile Idiopathic Arthritis (JIA). However, TNF-α is critical in immune function, raising concerns of…Abstract Number: 2167 • 2013 ACR/ARHP Annual Meeting
23-Valent Polysaccharide Pneumococcal Vaccine in Juvenile Idiopathic Arthritis Patients: Anti-Tumor Necrosis Factor Therapy Role in Short and Long-Term Immunogenicity
Background/Purpose: There is no study regarding short and long-term assessments of 23-valent polysaccharide pneumococcal vaccine (PPV23) in juvenile idiopathic arthritis (JIA) under biologic therapy. The objectives…